Martin de Bock
Overview
Explore the profile of Martin de Bock including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
722
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saboo B, Garg S, Bergenstal R, Battelino T, Ceriello A, Choudhary P, et al.
Diabetes Technol Ther
. 2025 Feb;
PMID: 39981664
No abstract available.
2.
Dovc K, Neuman V, Gita G, Cherubini V, Alonso G, Fritsch M, et al.
Diabetes Care
. 2025 Feb;
PMID: 39965057
Objective: This study examined the association between diabetic ketoacidosis (DKA) at type 1 diabetes diagnosis and long-term glycemic outcomes, insulin requirements, BMI SDS, and diabetes technology uptake in youth. Research...
3.
Wilkinson T, Meier R, Hewapathirana N, Lever C, Donnelly S, Sampson R, et al.
Diabetes Technol Ther
. 2025 Jan;
PMID: 39869185
This study evaluated a next-generation automated insulin delivery (AID) algorithm for Omnipod in type 1 and type 2 diabetes across multiple phases: 14-day run-in with usual therapy, 48-h AID use...
4.
Conway R, Snell-Bergeon J, Honda-Kohmo K, Peddi A, Isa S, Sulong S, et al.
J Endocr Soc
. 2024 Dec;
9(1):bvae210.
PMID: 39703363
Globally, nearly 9 million people are living with type 1 diabetes (T1D). Although the incidence of T1D is not affected by socioeconomic status, the development of complications and limited access...
5.
de Bock M, Agwu J, Deabreu M, Dovc K, Maahs D, Marcovecchio M, et al.
Horm Res Paediatr
. 2024 Dec;
97(6):546-554.
PMID: 39701064
The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults...
6.
Sehgal S, de Bock M, Grosman B, Williman J, Kurtz N, Guzman V, et al.
BMC Endocr Disord
. 2024 Aug;
24(1):167.
PMID: 39215272
Background: Multiple clinician adjustable parameters impact upon glycemia in people with type 1 diabetes (T1D) using Medtronic Mini Med 780G (MM780G) AHCL. These include glucose targets, carbohydrate ratios (CR), and...
7.
Payne M, Pooke F, Wilkinson T, Holder-Pearson L, Chamberlain B, de Bock M, et al.
BMC Endocr Disord
. 2024 Aug;
24(1):134.
PMID: 39090697
Background: Use of Continuous Subcutaneous Insulin Infusion (CSII) has been shown to improve glycemic outcomes in Type 1 Diabetes (T1D), but high costs limit accessibility. To address this issue, an...
8.
Stedman L, Williman J, Burnside M, Davies H, Jefferies C, Marsters B, et al.
N Z Med J
. 2024 Jul;
137(1598):14-21.
PMID: 38963927
Aim: We investigated if continuous glucose monitoring (CGM) in children with type 1 diabetes (T1D) within 12 months of being diagnosed modifies the development of glycaemic outcome inequity on the...
9.
Fisher C, Williman J, Burnside M, Davies H, Jefferies C, Paul R, et al.
J Paediatr Child Health
. 2024 May;
60(6):222-228.
PMID: 38750670
Aims: To survey the national workforce that manages children and adolescents with type 1 diabetes (T1D) in Aotearoa New Zealand and compare with glycaemic outcomes for 2021. Methods: A representative...
10.
Griffin C, Roxburgh E, Owens N, Sanders O, Walsh S, Hudson C, et al.
N Z Med J
. 2024 Apr;
137(1593):14-30.
PMID: 38603784
Aims: To examine the impact of intensive management of type 1 diabetes (T1D) from diagnosis on HbA1c 12 months from diagnosis. Methods: HbA1c measured 12 months after diagnosis for 70...